Teri B Lawler, | |
160 Malcolm Forest Rd, New Castle, DE 19720-8746 | |
(302) 743-5486 | |
(302) 327-4822 |
Full Name | Teri B Lawler |
---|---|
Gender | Female |
Speciality | Counselor - Mental Health |
Location | 160 Malcolm Forest Rd, New Castle, Delaware |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1083758973 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TS0200X | Psychologist - School | 2101 (Delaware) | Secondary |
101YM0800X | Counselor - Mental Health | PC-0000970 (Delaware) | Primary |
Mailing Address | Practice Location Address |
---|---|
Teri B Lawler, 160 Malcolm Forest Rd, New Castle, DE 19720-8746 Ph: (302) 743-5486 | Teri B Lawler, 160 Malcolm Forest Rd, New Castle, DE 19720-8746 Ph: (302) 743-5486 |
News Archive
Could it be the potato salad? Young adults who frequently attend religious activities are 50 percent more likely to become obese by middle age as young adults with no religious involvement, according to new Northwestern Medicine research.
Treating metastatic non-small cell lung cancer patients with the immunotherapy drug pembrolizumab after they've completed locally ablative therapy – meaning all known sites of their cancer were either treated with surgery, radiation, or other definitive treatments – almost tripled the median progression-free survival compared to the historical average.
Sonomax Hearing Healthcare Inc. is pleased to announce that it has signed a five year license agreement with Hearing Coach Africa (Pty). The agreement for V3 hearing protectors specifies quarterly commitments over five years, totaling a minimum of $1,000,000. The agreement is renewable for an additional 5 years if all contractual conditions and minimum quarterly commitments are met.
On March 10-11, 2010, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) - including the Pulmonary-Allergy Drugs and the Drug Safety and Risk Management Advisory Committees - discussed the design of post-marketing safety studies for long-acting beta-agonist (LABA)-containing products in the U.S., including SYMBICORT® (budesonide/formoterol fumarate dihydrate).
› Verified 7 days ago